Publications by authors named "Hussein Gaith"
Article Synopsis
- Ibrutinib is approved for treating chronic lymphocytic leukemia (CLL) but its effectiveness for multiple myeloma (MM) is still under research.
- A case study showed a patient with CLL developed MM while being treated with ibrutinib.
- This suggests that ibrutinib may not be effective in treating multiple myeloma.